RU2008102928A - Лечение инфекций, вызванных грибками и/или простейшими одноклеточными организмами - Google Patents
Лечение инфекций, вызванных грибками и/или простейшими одноклеточными организмами Download PDFInfo
- Publication number
- RU2008102928A RU2008102928A RU2008102928/13A RU2008102928A RU2008102928A RU 2008102928 A RU2008102928 A RU 2008102928A RU 2008102928/13 A RU2008102928/13 A RU 2008102928/13A RU 2008102928 A RU2008102928 A RU 2008102928A RU 2008102928 A RU2008102928 A RU 2008102928A
- Authority
- RU
- Russia
- Prior art keywords
- arginine
- polypeptide
- tryptophan
- phenylalanine
- use according
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 32
- 229920001184 polypeptide Polymers 0.000 claims abstract 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 23
- 239000004475 Arginine Substances 0.000 claims abstract 13
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract 13
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract 12
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract 12
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract 12
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract 12
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract 11
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract 11
- 108091016585 CD44 antigen Proteins 0.000 claims abstract 9
- 102000008055 Heparan Sulfate Proteoglycans Human genes 0.000 claims abstract 9
- 229920002971 Heparan sulfate Polymers 0.000 claims abstract 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract 9
- 108090000054 Syndecan-2 Proteins 0.000 claims abstract 9
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract 9
- 229960000310 isoleucine Drugs 0.000 claims abstract 9
- 229930182817 methionine Natural products 0.000 claims abstract 9
- 235000018417 cysteine Nutrition 0.000 claims abstract 8
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract 8
- 150000001413 amino acids Chemical group 0.000 claims abstract 7
- 230000002265 prevention Effects 0.000 claims abstract 7
- 241000233866 Fungi Species 0.000 claims abstract 6
- 101710095342 Apolipoprotein B Proteins 0.000 claims abstract 5
- 102100040202 Apolipoprotein B-100 Human genes 0.000 claims abstract 5
- 102000000853 LDL receptors Human genes 0.000 claims abstract 5
- 108010001831 LDL receptors Proteins 0.000 claims abstract 5
- 235000001014 amino acid Nutrition 0.000 claims abstract 5
- 102000005962 receptors Human genes 0.000 claims abstract 5
- 108020003175 receptors Proteins 0.000 claims abstract 5
- 102100029470 Apolipoprotein E Human genes 0.000 claims abstract 4
- 101710095339 Apolipoprotein E Proteins 0.000 claims abstract 4
- 244000005700 microbiome Species 0.000 claims abstract 3
- 102000007592 Apolipoproteins Human genes 0.000 claims abstract 2
- 108010071619 Apolipoproteins Proteins 0.000 claims abstract 2
- 125000000539 amino acid group Chemical group 0.000 claims abstract 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 239000012634 fragment Substances 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 238000006467 substitution reaction Methods 0.000 claims abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 8
- 239000004472 Lysine Substances 0.000 claims 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 7
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 6
- 238000000034 method Methods 0.000 claims 4
- 229940024606 amino acid Drugs 0.000 claims 3
- 101150102415 Apob gene Proteins 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims 1
- 101150037123 APOE gene Proteins 0.000 claims 1
- 241000224422 Acanthamoeba Species 0.000 claims 1
- 241000235349 Ascomycota Species 0.000 claims 1
- 241000228212 Aspergillus Species 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 101100216294 Danio rerio apoeb gene Proteins 0.000 claims 1
- 241000223218 Fusarium Species 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 241000224016 Plasmodium Species 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 229940124558 contraceptive agent Drugs 0.000 claims 1
- 239000003433 contraceptive agent Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N37/30—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the groups —CO—N< and, both being directly attached by their carbon atoms to the same carbon skeleton, e.g. H2N—NH—CO—C6H4—COOCH3; Thio-analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0513096.8A GB0513096D0 (en) | 2005-06-28 | 2005-06-28 | Treatment of microbial infections |
| GB0513096.8 | 2005-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008102928A true RU2008102928A (ru) | 2009-08-10 |
Family
ID=34856225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008102928/13A RU2008102928A (ru) | 2005-06-28 | 2006-06-26 | Лечение инфекций, вызванных грибками и/или простейшими одноклеточными организмами |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20080207508A1 (enExample) |
| EP (1) | EP1896502B1 (enExample) |
| JP (1) | JP2008546831A (enExample) |
| KR (2) | KR20110099069A (enExample) |
| CN (1) | CN101208355A (enExample) |
| AU (1) | AU2006263600B2 (enExample) |
| BR (1) | BRPI0612103A2 (enExample) |
| CA (1) | CA2610720A1 (enExample) |
| DK (1) | DK1896502T3 (enExample) |
| ES (1) | ES2427171T3 (enExample) |
| GB (1) | GB0513096D0 (enExample) |
| PL (1) | PL1896502T3 (enExample) |
| RU (1) | RU2008102928A (enExample) |
| WO (1) | WO2007000584A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0329958D0 (en) * | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
| GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
| GB0513096D0 (en) | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
| ITTO20080894A1 (it) * | 2008-12-02 | 2010-06-03 | Bioindustry Park Del Canavese S P A | Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso |
| JP5463515B2 (ja) * | 2009-02-12 | 2014-04-09 | 独立行政法人農業生物資源研究所 | 抗微生物ペプチドを固定化した素材 |
| CN104837860A (zh) * | 2012-09-07 | 2015-08-12 | 新加坡科技研究局 | 肽及其用途 |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| HRP20191400T1 (hr) * | 2014-12-24 | 2019-11-15 | Aadigen Llc | Peptidi i nanočestice za unutarstaničnu isporuku molekula |
| SG11201708815UA (en) * | 2015-05-29 | 2017-12-28 | Hexima Ltd | A method of in vivo treatment |
| CN105749250A (zh) * | 2016-03-14 | 2016-07-13 | 吉林大学 | 林蛙抗菌肽在治疗灰指甲的药物制备中的用途 |
| KR102677968B1 (ko) * | 2021-12-20 | 2024-06-26 | 세메스 주식회사 | 버퍼 유닛 및 이를 포함하는 기판 처리 장치 |
| CN116376795B (zh) * | 2023-03-29 | 2023-11-07 | 中国水产科学研究院珠江水产研究所 | 一种表达hsp70的重组乳酸菌及其制备方法与应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
| US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
| FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
| GB9705831D0 (en) | 1997-03-20 | 1997-05-07 | Univ Leicester | Oxidised ldl |
| KR100314721B1 (ko) | 1998-01-22 | 2001-11-23 | 김일웅 | 생물학적 활성이 있는 신규한 펩타이드 |
| US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
| AU2997099A (en) | 1998-03-11 | 1999-09-27 | Duke University | Methods of suppressing microglial activation |
| US6664230B1 (en) * | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| GB0103424D0 (en) | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| US20040014955A1 (en) | 2001-12-17 | 2004-01-22 | Carlos Zamudio | Identification of essential genes of cryptococcus neoformans and methods of use |
| US20050058689A1 (en) * | 2003-07-03 | 2005-03-17 | Reactive Surfaces, Ltd. | Antifungal paints and coatings |
| US20050208078A1 (en) * | 2003-11-20 | 2005-09-22 | Hoffman Stephen L | Methods for the prevention of malaria |
| JP4786538B2 (ja) | 2003-10-01 | 2011-10-05 | チルドレンズ ホスピタル アンド リサーチ センター アット オークランド | 親油性薬物送達ビヒクルおよびその使用方法 |
| GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
| ITFI20030324A1 (it) | 2003-12-22 | 2005-06-23 | Celbo S R L | Gruppo guidafilo per distribuire ed avvolgere filati per formare bobine. |
| GB0329958D0 (en) * | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
| GB0404374D0 (en) * | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
| GB0513096D0 (en) | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
-
2005
- 2005-06-28 GB GBGB0513096.8A patent/GB0513096D0/en not_active Ceased
-
2006
- 2006-06-26 US US11/916,627 patent/US20080207508A1/en not_active Abandoned
- 2006-06-26 BR BRPI0612103-9A patent/BRPI0612103A2/pt not_active IP Right Cessation
- 2006-06-26 RU RU2008102928/13A patent/RU2008102928A/ru not_active Application Discontinuation
- 2006-06-26 WO PCT/GB2006/002350 patent/WO2007000584A1/en not_active Ceased
- 2006-06-26 CN CNA200680023372XA patent/CN101208355A/zh active Pending
- 2006-06-26 KR KR1020117019503A patent/KR20110099069A/ko not_active Ceased
- 2006-06-26 CA CA002610720A patent/CA2610720A1/en not_active Abandoned
- 2006-06-26 PL PL06755636T patent/PL1896502T3/pl unknown
- 2006-06-26 EP EP06755636.5A patent/EP1896502B1/en not_active Not-in-force
- 2006-06-26 DK DK06755636.5T patent/DK1896502T3/da active
- 2006-06-26 JP JP2008518952A patent/JP2008546831A/ja active Pending
- 2006-06-26 KR KR1020087002160A patent/KR20080030060A/ko not_active Ceased
- 2006-06-26 ES ES06755636T patent/ES2427171T3/es active Active
- 2006-06-26 AU AU2006263600A patent/AU2006263600B2/en not_active Ceased
-
2011
- 2011-12-22 US US13/335,549 patent/US8916516B2/en not_active Expired - Fee Related
-
2014
- 2014-11-14 US US14/542,319 patent/US20150190462A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007000584A8 (en) | 2013-01-24 |
| KR20080030060A (ko) | 2008-04-03 |
| US20150190462A1 (en) | 2015-07-09 |
| US20080207508A1 (en) | 2008-08-28 |
| GB0513096D0 (en) | 2005-08-03 |
| JP2008546831A (ja) | 2008-12-25 |
| US8916516B2 (en) | 2014-12-23 |
| PL1896502T3 (pl) | 2013-12-31 |
| US20120258907A1 (en) | 2012-10-11 |
| ES2427171T3 (es) | 2013-10-29 |
| AU2006263600B2 (en) | 2012-09-20 |
| BRPI0612103A2 (pt) | 2011-12-20 |
| EP1896502B1 (en) | 2013-07-31 |
| WO2007000584A1 (en) | 2007-01-04 |
| AU2006263600A1 (en) | 2007-01-04 |
| CA2610720A1 (en) | 2007-01-04 |
| HK1113162A1 (en) | 2008-10-24 |
| DK1896502T3 (da) | 2013-10-14 |
| CN101208355A (zh) | 2008-06-25 |
| EP1896502A1 (en) | 2008-03-12 |
| KR20110099069A (ko) | 2011-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1469876B1 (en) | Antimicrobial cationic peptides and formulations thereof | |
| Zhao et al. | Molecular hydrogels of therapeutic agents | |
| AU2014263279B2 (en) | Antimicrobial peptide | |
| CN1925866B (zh) | 细菌感染的治疗 | |
| DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| AU2002324752A1 (en) | Antimicrobial cationic peptides and formulations thereof | |
| EP3852778A2 (en) | Bioactive peptides derived from snakes | |
| US7381707B2 (en) | Treatment of dry eye | |
| ZA200706349B (en) | Poly(ethylene glycol)-modified human growth hormone and use thereof | |
| DE60231131D1 (de) | Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose | |
| AR073810A1 (es) | Polipeptidos que tienen actividad antimicrobiana | |
| JP2008546831A5 (enExample) | ||
| WO2011157716A1 (en) | Novel peptides for wound healing | |
| AU2006263600B2 (en) | Treatment of fungal and/or protist infections | |
| RU2011133224A (ru) | Новые фармацевтические композиции | |
| RU2010128602A (ru) | Циклический белок, не содержащий остатков цистеина | |
| EP4228677A1 (en) | Novel bioactive peptide combinations and uses thereof | |
| CN101878226A (zh) | 精氨酸取代的新型合成肽及其应用 | |
| WO2009070564A2 (en) | Compositions and methods for prevention of infection in transcutaneous osseointegrated implants | |
| WO2013158773A2 (en) | Rnase 7 antimicrobial peptides | |
| Balducci et al. | Optimizing non-crosslinked type I collagen barrier membranes for guided bone regeneration: a comparative study of a BMP-2 derived peptide adsorption and covalent grafting | |
| RU2008106460A (ru) | Антимикробный агент, взаимодействующий с системой комплемента | |
| Ohliger | Effect of Osteoactivin and Bone Morphogenetic Protein-2 on soft tissue in Rat Spinal Fusion Model | |
| ATE526984T1 (de) | Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen | |
| CA3116537A1 (en) | Antimicrobial peptides and methods of using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110421 |